These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1712081)

  • 1. Defective acidification of intracellular organelles in cystic fibrosis.
    Barasch J; Kiss B; Prince A; Saiman L; Gruenert D; al-Awqati Q
    Nature; 1991 Jul; 352(6330):70-3. PubMed ID: 1712081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective acidification of the biosynthetic pathway in cystic fibrosis.
    Barasch J; al-Awqati Q
    J Cell Sci Suppl; 1993; 17():229-33. PubMed ID: 7511615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective regulatory volume decrease in human cystic fibrosis tracheal cells because of altered regulation of intermediate conductance Ca2+-dependent potassium channels.
    Vázquez E; Nobles M; Valverde MA
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5329-34. PubMed ID: 11309505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):457-64. PubMed ID: 9261986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator and H+ permeability in regulation of Golgi pH.
    Machen TE; Chandy G; Wu M; Grabe M; Moore HP
    JOP; 2001 Jul; 2(4 Suppl):229-36. PubMed ID: 11875264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship.
    Gabriel SE; Clarke LL; Boucher RC; Stutts MJ
    Nature; 1993 May; 363(6426):263-8. PubMed ID: 7683773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered terminal glycosylation and the pathophysiology of CF lung disease.
    Rhim AD; Stoykova LI; Trindade AJ; Glick MC; Scanlin TF
    J Cyst Fibros; 2004 Aug; 3 Suppl 2():95-6. PubMed ID: 15463936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis transmembrane conductance regulator protein: what is its role in cystic fibrosis?
    Richardson PS; Alton EW
    Eur Respir J; 1993 Feb; 6(2):160-2. PubMed ID: 7680321
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence against defective trans-Golgi acidification in cystic fibrosis.
    Seksek O; Biwersi J; Verkman AS
    J Biol Chem; 1996 Jun; 271(26):15542-8. PubMed ID: 8663158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of CFTR bearing the delta F508 mutation.
    Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
    J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis. Acidification indication.
    Welsh MJ
    Nature; 1991 Jul; 352(6330):23-4. PubMed ID: 1712079
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.
    Poschet JF; Boucher JC; Tatterson L; Skidmore J; Van Dyke RW; Deretic V
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13972-7. PubMed ID: 11717455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy.
    Hyde SC; Gill DR; Higgins CF; Trezise AE; MacVinish LJ; Cuthbert AW; Ratcliff R; Evans MJ; Colledge WH
    Nature; 1993 Mar; 362(6417):250-5. PubMed ID: 7681548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties.
    Sheppard DN; Rich DP; Ostedgaard LS; Gregory RJ; Smith AE; Welsh MJ
    Nature; 1993 Mar; 362(6416):160-4. PubMed ID: 7680769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients.
    Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C
    Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective formation of PKA/CnA-dependent annexin 2-S100A10/CFTR complex in DeltaF508 cystic fibrosis cells.
    Borthwick LA; Riemen C; Goddard C; Colledge WH; Mehta A; Gerke V; Muimo R
    Cell Signal; 2008 Jun; 20(6):1073-83. PubMed ID: 18346874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic lipid:pDNA complexes for the treatment of cystic fibrosis.
    Eastman SJ; Scheule RK
    Curr Opin Mol Ther; 1999 Apr; 1(2):186-96. PubMed ID: 11715942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.